References
- Organisation Mondial de la Santé (OMS). Cancer http://www.who.int/cancer/fr/
consultée le 25 avril 2015. Google
Scholar
- Organisation Mondial de la Santé (OMS). La santé des
femmes, Centre des médias, aide-mémoire N°334, Septembre 2013 http://www.who.int/mediacentre/factsheets/fs334/fr/
Consultée le 24 avril 2015. Google
Scholar
- Bosetti C, BertuccioP, Levi F, Chatenoud L et al. The decline in breast cancer mortality in Europe: an update (to 2009). Breast. 2012 Feb; 21(1):77-82. PubMed | Google Scholar
- Siegle R, Desantis C, Virgo K. Cancer Treatment and Survivorship Statistics, 2012. CA Cancer J Clin. 2012; 62(4):220-41. PubMed | Google Scholar
- Goncalves A, Tredan O, Villanueva C, Dumontet C. Antibody-drug conjugates in oncology: from the concept to trastuzumabemtansine (T-DM1). Bull Cancer. 2012 December; 99 (12): 1183-91. PubMed | Google Scholar
- Akram M, Siddiqui SA. Breast cancer management: past, present and evolving. Indian J Cancer. 2012; 49(3):277-82. PubMed | Google Scholar
- Hiram S, Sara S. The continuing importance of adequate surgery for operable breast cancer: significant salvage of node positive patients without adjuvant chemotherapy. CA Cancer J Clinvol. August 1982; 32 (4) July:242-56. PubMed | Google Scholar
- Ly M, Antoine M, Andre F, Callard P, Bernaudin JF, Diallo DA. Le cancer du sein chez la femme de l'Afrique sub-saharienne. Bull Cancer. 2011; 7 (98): 797-806. PubMed | Google Scholar
- Honig A, Rieger L, Sutterlin M et al. State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments. Ger Med Sci. 2005; 3 (8): 1- 44. PubMed | Google Scholar
- Cutuli B, Lemanski C et al. Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. Br J Cancer. 2009 April 7; 100(7): 1048-1054. PubMed | Google Scholar
- Greenberg CC, Lipsitz SR, Hughes ME, Edge SB et al. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Annals of surgery. 2011;254(2):339-45. PubMed | Google Scholar
- Dem A, Dieng MM, Ndiaye Ba N, Gaye PM, Gaye-Fall MC, Diouf D. Breast lobular carcinoma: 43 cases report. CarcinolClinAfrique. 2011; 10 (1): 5- 6. PubMed | Google Scholar
- Damoaliga G. Les difficultés diagnostiques et thérapeutiques des cancers du sein chez la femme au CHU-YO : à propos de 55 cas. Thèse de médecine N°106Université de Ouagadougou 2009; 83p. Google Scholar
- Jihen J, Habib A, Nabil T, SourourY et al. Le cancer du sein chez la femme âgée: épidemiologie et caractéristiques cliniques. J I M Sfax. Juin-Décembre2010; 19(20): 36-46. PubMed | Google Scholar
- Bijek JH, Aucouturier JS, Doridot V et al. Lymphocèles axillaires après curage ou prélèvement du ganglion sentinelle en cas de cancer du sein. Bull Cancer. 2005; 2 (92): 179-83. PubMed | Google Scholar
- Erdem E, Alagol H. Results of breast conserving surgery in clinical stage I-II breast carcinoma. Indian J Surg. January-February 2009;71:29-34. PubMed | Google Scholar
- Liu C, Pan H, Li Z, Shi L, Huang T. Histopathological features of invasion of breast invasive ductal carcinoma and safety of breast-conserving surgery. J HuazhongUnivSciTechnolog Med Sci. 2009 Feb;29(1):50-2. PubMed | Google Scholar
- Andeweg CS, Schriek MJ, Heisterkamp J, Roukema A. Seroma formation in two cohorts after axillar y lymph node dissection in breast cancer surgery: does timing of drain removal matter? The Breast Journal. 2011;17(4):359-64. PubMed | Google Scholar
- Lumachi F, Brandes AA, Burelli P, Basso SM, Lacobonne M, Ermani M. Seroma prevention following axillary dissection in patients with breast cancer by using ultrasound scissors: a prospective clinical study. Eur J SurgOncol. 2004; 30 (5):526-30. PubMed | Google Scholar
- Mansel RE, Fallowfield L, Kissin M, Goyal A et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98(9): 599-609. PubMed | Google Scholar